Meaning-Centered Psychotherapy for Bone Marrow Transplant
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether Meaning-Centered Psychotherapy (MCP-Dyad) benefits people recovering from a stem cell transplant and their caregivers. The therapy helps them find meaning, manage challenges, and improve communication during recovery. Participants will either attend sessions focused on these goals or receive standard care and resources. This trial suits individuals who have undergone a stem cell transplant for blood cancer and their primary support person, provided both can use a smartphone, computer, or tablet for the study. As an unphased trial, it offers a unique opportunity to explore innovative therapy methods that could enhance recovery experiences.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on a support program rather than medication changes.
What prior data suggests that Meaning-Centered Psychotherapy is safe for bone marrow transplant survivors and caregivers?
Research has shown that Meaning-Centered Psychotherapy (MCP) is a safe and suitable treatment for caregivers of stem cell transplant patients. Studies have found that MCP, particularly when delivered by nurses via telehealth, is practical and well-received by participants. The therapy is generally manageable, with no major negative effects reported. MCP aids individuals in finding meaning and coping with challenging experiences, which can be beneficial after a difficult medical treatment like a stem cell transplant. Previous studies have not identified any specific safety concerns, indicating it is a low-risk option for participants.12345
Why are researchers excited about this trial?
Researchers are excited about Meaning-Centered Psychotherapy (MCP) for bone marrow transplant patients because it offers a unique approach to addressing the emotional and psychological challenges these patients face. Unlike standard care, which focuses on educational resources and basic support, MCP emphasizes personal reflection and the application of four sources of meaning to enhance patients' quality of life. This psychotherapy aims to improve patients' mental well-being by helping them find deeper purpose and meaning during a challenging treatment journey. By fostering a sense of meaning, MCP could potentially improve emotional resilience and overall outcomes for patients undergoing bone marrow transplants.
What evidence suggests that Meaning-Centered Psychotherapy is effective for bone marrow transplant recovery?
Research has shown that Meaning-Centered Psychotherapy (MCP) can significantly reduce existential distress, a deep concern about life's meaning and purpose. In this trial, participants in the MCP-Dyad arm will engage in this therapy to enhance spiritual well-being, crucial for those recovering from stem cell transplants. This therapy aids individuals in finding meaning in their experiences, which can enhance their overall quality of life. For patients undergoing challenging treatments like bone marrow transplants, maintaining mental health is vital. MCP has demonstrated effectiveness by fostering a positive outlook and improved coping strategies.678910
Who Is on the Research Team?
Natalie McAndrew, PhD, RN
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults who have received a bone marrow (stem cell) transplant and their main caregivers. Both must be willing to participate together as a pair during the recovery period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in Meaning-Centered Psychotherapy (MCP-Dyad) sessions to address existential distress
Follow-up
Participants are monitored for changes in relationship quality, spiritual well-being, and coping strategies
What Are the Treatments Tested in This Trial?
Interventions
- Meaning-Centered Psychotherapy
Trial Overview
The study compares Meaning-Centered Psychotherapy, which helps patients and caregivers find meaning and cope after transplant, with usual care. It looks at whether this therapy is practical and helpful for both survivors and their caregivers.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The MCP-Dyad arm participants will meet with an MCP-Dyad interventionist to engage in didactic content, reflection, and discussion to teach participants how to apply four sources of meaning to their lives
The standard of care arm will receive standard resources and consultations for HSCT care, which include a joint educational class for patients and caregivers before and after treatment.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Citations
Value-Based Care in Hematopoietic Cell Transplantation and ...
The goal of value-based care is to have better health outcomes with streamlined processes, improved patient experience, and lower costs.
Biobehavioral Research and Hematopoietic Stem Cell ...
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study.
Utilization of hematopoietic stem cell transplantation for the ...
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy. Bone Marrow Transplant. 2016 ...
Supporting Hematopoietic Stem Cell Transplant...
MCP‐C was adapted from Meaning‐Centered Psychotherapy (MCP), an intervention that is highly effective in decreasing existential distress and enhancing spiritual ...
Bone Marrow Transplant Clinical Trials
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics, and effectiveness of SER-155 in adults undergoing hematopoietic stem cell ...
Meaning-Centered Psychotherapy for Addressing ...
The purpose of this study is to learn whether Meaning-Centered Psychotherapy (MCP-Dyad) is practical, acceptable, and helpful to survivors ...
Supporting Hematopoietic Stem Cell Transplant Family ...
Conclusions: Nurse-delivered MCP-C via telehealth is feasible and acceptable for caregivers of HSCT recipients. A future randomized controlled trial is needed ...
Prolonged Hospitalization for Hematopoietic Cell ...
Patients who experienced lengthy hospitalization for HCT reported persistent and worse quality of life at 3 and 6 months, as well as increased symptom burden ...
9.
nmdp.org
nmdp.org/what-we-do/news/press-releases/nmdp-to-present-new-stem-cell-transplantation-dataNMDP to Present New Stem Cell Transplantation Data at ...
A chief focus will be sharing interim findings from ACCESS, the prospective, multi-center, Phase II clinical trial of HCT using human leukocyte ...
10.
repository.escholarship.umassmed.edu
repository.escholarship.umassmed.edu/bitstreams/1a4cbe36-9b5a-4e2f-a0c5-275a50ab26ce/downloadPsychosocial assessment practices for hematopoietic stem ...
Psychosocial health predicts and contributes to medical outcomes for patients undergoing hematopoietic stem cell transplantation. (HSCT).
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.